BioMedLib Search Engine [ goto HOMEPAGE ]

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.

BACKGROUND: Adenocarcinoma of the small bowel is relatively less common than malignancies of the esophagus, stomach, and colorectum.

In small bowel adenocarcinoma, various prognostic factors influence the disease-free status and overall survival rates.

MATERIALS AND METHODS: Eighty patients who were diagnosed with small bowel adenocarcinoma and treated at our institute between 1983 and 2003 were retrospectively reviewed.

CONCLUSIONS: Poor prognosis of small bowel adenocarcinoma may be related to a delay in the diagnosis and treatment of the disease.

Curative resection is the aim of surgical treatment for small bowel adenocarcinoma.

[MeSH-major] Adenocarcinoma / pathology. Intestinal Neoplasms / pathology. Intestine, Small

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Endoscopy. 2003 Dec;35(12):985-91 [14648408.001]

[Cites] AJR Am J Roentgenol. 2001 Jan;176(1):147-51 [11133555.001]

[Cites] Hepatogastroenterology. 2001 May-Jun;48(39):727-32 [11462914.001]

[Cites] Gastrointest Endosc. 2001 Feb;53(2):216-20 [11174299.001]

[Cites] CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1 [10200775.001]

[Cites] Cancer. 2004 Aug 1;101(3):518-26 [15274064.001]

[Cites] AJR Am J Roentgenol. 2000 Dec;175(6):1627-30 [11090391.001]

[Cites] Am J Surg. 1984 Jan;147(1):66-71 [6691554.001]

[Cites] Abdom Imaging. 2000 May-Jun;25(3):246-50 [10823443.001]

[Cites] Oncology (Williston Park). 1997 Apr;11(4):529-36; discussion 545, 549-50 [9130275.001]

[Cites] Abdom Imaging. 2001 Sep-Oct;26(5):474-80 [11503082.001]

[Cites] Ann Surg Oncol. 1994 May;1(3):183-8 [7842287.001]

[Cites] Surg Clin North Am. 1986 Aug;66(4):779-85 [3738698.001]

[Cites] Am J Surg. 1997 Mar;173(3):237-9 [9124635.001]

[Cites] Arch Surg. 2000 Jun;135(6):635-41; discussion 641-2 [10843358.001]

[Cites] Gut. 2004 Dec;53(12):1866-75 [15542530.001]

[Cites] Cancer. 1999 Dec 15;86(12):2693-706 [10594865.001]

[Cites] Arch Surg. 1992 May;127(5):557-60 [1349472.001]

[Cites] Gastrointest Radiol. 1991 Spring;16(2):115-9 [2016021.001]

[Cites] J Gastrointest Surg. 1998 Jan-Feb;2(1):79-87 [9841972.001]

[Cites] Ann Surg Oncol. 1994 Jul;1(4):290-5 [7850527.001]

[Cites] Am Surg. 2000 Jan;66(1):46-51 [10651347.001]

[Cites] J Comput Assist Tomogr. 1997 Nov-Dec;21(6):986-91 [9386295.001]

[Cites] Dis Colon Rectum. 2002 Nov;45(11):1496-502 [12432298.001]

[Cites] Surg Endosc. 1997 Dec;11(12 ):1153-8 [9373284.001]

[Cites] Ann Surg. 1997 Mar;225(3):262-7 [9060581.001]

[Cites] AJR Am J Roentgenol. 1989 May;152(5):995-8 [2705358.001]

[Cites] Liver Transpl. 2000 Jan;6(1):67-72 [10648580.001]

[Cites] Am J Surg. 2000 Jan;179(1):37-41 [10737576.001]

(PMID = 16479330.001).

[ISSN] 0364-2313

[Journal-full-title] World journal of surgery

[ISO-abbreviation] World J Surg

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma.

The aim of this study was to compare TRAIL/Apo2L expression in normal gastroesophageal (GE) junction, Barrett's esophagus with and without dysplasia, and associated adenocarcinoma.

Immunohistochemical evaluation of TRAIL expression was performed on formalin-fixed paraffin-embedded sections from 29 GE junction/esophageal biopsies, 20 gastric biopsies, 6 esophagectomies, 2 small bowel resection specimens, and 5 colon biopsies.

TRAIL was expressed in the foveolar epithelium of the histologically normal GE junctional mucosa and stomach as well as in the normal intestinal epithelium, with maximal expression in the surface epithelium.

TRAIL was rarely and weakly (1+) expressed in Barrett's esophagus with dysplasia (3/18, 16.7%) and adenocarcinoma (1/10, 10.0%) (P<0.001).

Similarities in the topographic pattern of TRAIL expression in the normal GE junction, stomach, small intestine, and colon suggest a common function of TRAIL throughout the gastrointestinal tract.

Genetic Alliance. consumer health - Barrett's Esophagus.

MedlinePlus Health Information. consumer health - Esophageal Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16785783.001).

[ISSN] 1541-2016

[Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM

[ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.

[Language] ENG

[Publication-type] Comparative Study; Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / TNF-Related Apoptosis-Inducing Ligand

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy.

BACKGROUND: Capsule endoscopy (CE) is increasingly being used to investigate the small bowel for various indications, including obscure GI bleeding (OGB).

Double-balloon enteroscopy (DBE) is a new endoscopic technique developed to potentially view the entire small intestine while allowing therapeutic options to be carried out when appropriate.

OBJECTIVE: We described 4 patients with small-bowel pathology missed on CE but detected by DBE.

INTERVENTIONS: DBE followed by surgical exploration and resection of small-bowel pathology.

Definitive treatment of small-bowel pathology by surgical resection.

RESULTS: CE did not identify the small-bowel pathology in all 4 patients.

The 3 patients with OGB had small-bowel masses found by DBE.

Two of these were GI stromal tumors and one was an adenocarcinoma.

LIMITATIONS: Retrospective study and small sample size.

If there is a high index of suspicion of small-bowel pathology despite a negative CE, DBE should be performed.

[MeSH-major] Endoscopy, Gastrointestinal / methods. Intestinal Neoplasms / pathology. Intestine, Small / pathology

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16923502.001).

[ISSN] 0016-5107

[Journal-full-title] Gastrointestinal endoscopy

[ISO-abbreviation] Gastrointest. Endosc.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

   

Advertisement

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Two patients were found to have lead-point intussusceptions and both had small-bowel adenocarcinoma, and 10/14 had severe villous atrophy (subtotal or total).

Among those with established celiac disease, IS was detected early, within 3 years of diagnosis.

Adenocarcinoma needs to be excluded.

[MeSH-minor] Abdominal Pain / epidemiology. Abdominal Pain / pathology. Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Adult. Atrophy. Biopsy. Capsule Endoscopy. Chi-Square Distribution. Databases, Factual. Female. Follow-Up Studies. Humans. Incidental Findings. Intestinal Neoplasms / epidemiology. Intestinal Neoplasms / pathology. Male. Middle Aged

Genetic Alliance. consumer health - Celiac Disease.

MedlinePlus Health Information. consumer health - Celiac Disease.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Pediatr Infect Dis J. 2006 Jan;25(1 Suppl):S22-9 [16397426.001]

[Cites] Turk J Gastroenterol. 2002 Mar;13(1):63-5 [16378278.001]

[Cites] Ann Surg. 2005 Aug;242(2):201-7 [16041210.001]

[Cites] Am J Surg. 1989 Jul;158(1):25-8 [2662787.001]

[Cites] Clin Radiol. 2007 Aug;62(8):792-7 [17604770.001]

[Cites] J Pediatr Surg. 1999 Dec;34(12 ):1833-5 [10626866.001]

[Cites] World J Gastroenterol. 2007 Mar 21;13(11):1696-700 [17461472.001]

[Cites] Radiology. 1999 Sep;212(3):853-60 [10478257.001]

[Cites] Clin Radiol. 1978 Sep;29(5):529-34 [710039.001]

[Cites] Am J Surg. 1997 Feb;173(2):88-94 [9074370.001]

[Cites] Aust N Z J Surg. 1981 Apr;51(2):179-80 [6940547.001]

[Cites] Gut. 2004 May;53(5):774 [15082608.001]

[Cites] Radiographics. 2006 May-Jun;26(3):733-44 [16702451.001]

[Cites] Eur J Radiol. 2007 Aug;63(2):302-6 [17336477.001]

[Cites] Trop Gastroenterol. 2005 Jan-Mar;26(1):38-9 [15974238.001]

[Cites] N Engl J Med. 2007 Oct 25;357(17):1731-43 [17960014.001]

[Cites] Dig Liver Dis. 2005 Jun;37(6):402-6 [15893278.001]

[Cites] Ann Surg. 1997 Aug;226(2):134-8 [9296505.001]

[Cites] Clin Radiol. 1998 Jan;53(1):53-7 [9464437.001]

[Cites] South Med J. 1989 Feb;82(2):215-28 [2916150.001]

[Cites] Radiology. 2003 Apr;227(1):68-72 [12668740.001]

[Cites] Gastrointest Endosc. 2005 Jul;62(1):55-61 [15990820.001]

[Cites] AJR Am J Roentgenol. 1986 Mar;146(3):527-31 [3484870.001]

[Cites] J Magn Reson Imaging. 2006 Sep;24(3):625-9 [16888777.001]

(PMID = 20033844.001).

[ISSN] 1573-2568

[Journal-full-title] Digestive diseases and sciences

[ISO-abbreviation] Dig. Dis. Sci.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Small bowel adenocarcinoma].

[Transliterated title] Adénocarcinome de l'intestin grêle.

Small bowel adenocarcinoma is a rare tumor.

Diagnosis is usually performed at an advanced stage because of non-specific nature of clinical manifestations.

New methods of radiological and endoscopic exploration of small intestine should allow earlier diagnosis.

A national prospective cohort study is currently evaluating the results of chemotherapy (recommended protocol: FOLFOX) as adjuvant and palliative treatment of small bowel adenocarcinoma.

[MeSH-major] Adenocarcinoma / etiology. Adenocarcinoma / therapy. Intestinal Neoplasms / etiology. Intestinal Neoplasms / therapy

[MeSH-minor] Chemotherapy, Adjuvant. Genetic Predisposition to Disease. Humans. Intestine, Small / pathology. Intestine, Small / surgery. Lymphatic Metastasis. Neoplasm Metastasis. Prognosis. Risk Factors

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright 2010 Elsevier Masson SAS. All rights reserved.

(PMID = 20537487.001).

[ISSN] 0399-8320

[Journal-full-title] Gastroentérologie clinique et biologique

[ISO-abbreviation] Gastroenterol. Clin. Biol.

[Language] fre

[Publication-type] English Abstract; Journal Article; Review

[Publication-country] France

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Complete response of an initially non-surgical adenocarcinoma of the duodenum to chemotherapy with the FOLFOX 4 regimen.

INTRODUCTION: The incidence of adenocarcinoma of the small bowel is very low in comparison with that of colorectal cancer.

No standard chemotherapy is defined for non-surgical adenocarcinoma of the small bowel.

CASE REPORT: We report here the case of a young patient with an initially non-surgical adenocarcinoma of the duodenum treated in a palliative setting with the FOLFOX 4 chemotherapy regimen.

CONCLUSION: The FOLFOX 4 regimen seems to be efficacious for some small-bowel adenocarcinomas and can be expected to lead to downstaging.

[MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Duodenal Neoplasms / drug therapy

MedlinePlus Health Information. consumer health - Intestinal Cancer.

Hazardous Substances Data Bank. FLUOROURACIL .

Hazardous Substances Data Bank. LEUCOVORIN .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] ANZ J Surg. 2001 Jul;71(7):428-37 [11450920.001]

[Cites] CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1 [10200775.001]

[Cites] Cancer. 2004 Aug 1;101(3):518-26 [15274064.001]

[Cites] J Gastrointest Surg. 2003 Nov;7(7):925-30 [14592670.001]

[Cites] Am J Surg. 1984 Jan;147(1):66-71 [6691554.001]

[Cites] J Clin Gastroenterol. 2001 Oct;33(4):267-82 [11588539.001]

[Cites] Am J Gastroenterol. 1994 May;89(5):699-701 [8172140.001]

[Cites] Oncology (Williston Park). 1997 Apr;11(4):529-36; discussion 545, 549-50 [9130275.001]

[Cites] Am J Surg. 1975 Dec;130(6):749-55 [1242874.001]

[Cites] Ann Surg Oncol. 1994 May;1(3):183-8 [7842287.001]

[Cites] Br J Cancer. 2006 Nov 6;95(9):1296-300 [17031398.001]

[Cites] Gastrointest Endosc Clin N Am. 2004 Jan;14(1):139-48 [15062387.001]

[Cites] Arch Surg. 2002 May;137(5):564-70; discussion 570-1 [11982470.001]

[Cites] Gastroenterology. 1993 Dec;105(6):1716-23 [8253348.001]

[Cites] Gastroenterology. 1994 Dec;107(6):1675-9 [7958678.001]

[Cites] Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):81-4 [8850266.001]

[Cites] Dig Dis Sci. 1992 Aug;37(8):1179-84 [1499440.001]

[Cites] Ann Surg Oncol. 1994 Jan;1(1):73-8 [7834432.001]

[Cites] Cancer. 1999 Dec 15;86(12):2693-706 [10594865.001]

[Cites] Am J Gastroenterol. 2006 Dec;101(12):2826-32 [17026561.001]

[Cites] Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):243-51 [9521441.001]

[Cites] Int J Epidemiol. 1996 Aug;25(4):722-8 [8921448.001]

[Cites] J Am Coll Surg. 1996 Aug;183(2):89-96 [8696551.001]

[Cites] Ann Oncol. 2003;14 Suppl 5:v61-118 [14684501.001]

(PMID = 19585173.001).

[ISSN] 1873-4626

[Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

[ISO-abbreviation] J. Gastrointest. Surg.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Organoplatinum Compounds; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Focal amyloidoma of the small bowel mimicking adenocarcinoma on CT.

[MeSH-major] Amyloidosis / radiography. Intestinal Diseases / radiography. Intestine, Small. Tomography, X-Ray Computed

[MeSH-minor] Adenocarcinoma / radiography. Aged. Contrast Media. Diagnosis, Differential. Humans. Intestinal Neoplasms / radiography. Male

MedlinePlus Health Information. consumer health - Amyloidosis.

MedlinePlus Health Information. consumer health - CT Scans.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16247131.001).

[ISSN] 0361-803X

[Journal-full-title] AJR. American journal of roentgenology

[ISO-abbreviation] AJR Am J Roentgenol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Contrast Media

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience.

OBJECTIVE: The objective of the study was to examine diagnosis and outcome in a series of patients with small bowel tumors detected by capsule endoscopy (CE) in three Australian centers.

Seventeen tumors were malignant: five adenocarcinomas, six carcinoids, two melanoma metastases, two gastrointestinal stromal tumors (GIST), one colon carcinoma metastasis, one non-Hodgkin's lymphoma.

Of the five patients with primary adenocarcinoma only one remains disease free.

CONCLUSIONS: Small bowel tumors are a significant finding at CE and are often missed by other methods of investigation.

[MeSH-major] Capsule Endoscopy. Intestinal Neoplasms / pathology. Intestinal Neoplasms / therapy. Intestine, Small

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17032187.001).

[ISSN] 0002-9270

[Journal-full-title] The American journal of gastroenterology

[ISO-abbreviation] Am. J. Gastroenterol.

[Language] eng

[Publication-type] Journal Article; Multicenter Study

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Proapoptotic effect on normal and tumor intestinal cells of cytostatic drugs with enterohepatic organotropism.

The proapoptotic effect of cisplatin bile acid derivatives Bamet-R2 [cis-diamminechloro-cholylglycinate-platinum(II)] and Bamet-UD2 [cis-diammine-bisursodeoxycholate-platinum(II)], developed to treat liver and intestinal tumors, was investigated in vitro using human enterohepatic cells HepG2 (hepatoblastoma), LS 174T (colon adenocarcinoma), and its cisplatin-resistant subline LS 174T/R.

The degree of necrosis (lactate dehydrogenase release) induced by these three drugs was small and similar in all cell types.

Oral administration of Bamet-UD2 to mice induced mild apoptosis in the small intestine (ileum > duodenum), which was not severe enough to modify its structure or function as determined by water absorption and glycocholic acid uptake by in situ perfused ileum.

These results indicate that Bamet-UD2 overcomes the resistance to cisplatin when this is due in part to enhanced ability of intestinal tumors to reduce intracellular cisplatin contents.

Moreover, its strong proapoptotic versus its weak pronecrotic effect together with its mild effect on normal tissues, including intestinal mucosa, may account for the high antitumor activity of Bamet-UD2 together with its very low toxicity.

[MeSH-major] Antineoplastic Agents / pharmacology. Apoptosis / drug effects. Intestinal Neoplasms / drug therapy. Intestine, Small / drug effects. Organoplatinum Compounds / pharmacology. Ursodeoxycholic Acid / analogs & derivatives

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15985617.001).

[ISSN] 0022-3565

[Journal-full-title] The Journal of pharmacology and experimental therapeutics

[ISO-abbreviation] J. Pharmacol. Exp. Ther.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Bamet-UD2; 0 / DNA Adducts; 0 / Organoplatinum Compounds; 0 / diamminebis(ursodeoxycholate(O,O'))platinum(II); 724L30Y2QR / Ursodeoxycholic Acid

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] A rare case of primary small bowel adenocarcinoma with intussusception.

In contrast with the colon tract, the incidence of primary malignancies in the small bowel is very low.

We report the case of a 51-year-old man presenting with jejunal intussusception due to a primary adenocarcinoma.

The patient was referred to our division for bowel obstruction.

Histological examination of the specimen resulted in a diagnosis of a primary adenocarcinoma of the small bowel.

In adult intestinal intussusception, resection without reduction is considered the optimal management if an underlying primary malignancy cannot be excluded.

[MeSH-major] Adenocarcinoma / complications. Intussusception / etiology. Jejunal Diseases / etiology. Jejunal Neoplasms / complications

MedlinePlus Health Information. consumer health - Intestinal Cancer.

MedlinePlus Health Information. consumer health - Small Intestine Disorders.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 20572601.001).

[ISSN] 0300-8916

[Journal-full-title] Tumori

[ISO-abbreviation] Tumori

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis.

PURPOSE: To prospectively evaluate the sensitivity and specificity of contrast material-enhanced and water-enhanced multidetector computed tomographic (CT) enteroclysis in depicting small-bowel neoplasms in symptomatic patients, with endoscopic, tissue, and follow-up findings as reference standards.

Two hundred nineteen patients (108 male, 111 female; age range, 17-98 years; mean, 53.1 years) with clinical suspicion of small-bowel neoplasm underwent contrast- and water-enhanced multidetector CT enteroclysis after normal findings of upper and lower gastrointestinal endoscopy.

The prospective interpretations of CT enteroclysis results include evaluation of focal bowel wall thickening, small-bowel masses, small-bowel stenosis, mesenteric stranding, enlarged mesenteric lymph nodes, and visceral metastasis.

The overall sensitivity and specificity in identifying patients with small-bowel lesions were 84.7% and 96.9%, respectively.

Findings of pathologic examination confirmed small-bowel tumor in 50 patients with carcinoid tumor (n = 19), adenocarcinoma (n = 7), lymphoma (n = 5), jejunal adenoma (n = 9), stromal tumor (n = 5), ectopic pancreas (n = 2), angiomatous mass (n = 2), or metastasis (n = 1).

CONCLUSION: Contrast- and water-enhanced multidetector CT enteroclysis had an overall accuracy of 84.7% for depiction of small-bowel neoplasms.

[MeSH-major] Intestinal Neoplasms / radiography. Intestine, Small. Tomography, X-Ray Computed / methods

[MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Contrast Media. Diagnosis, Differential. Endoscopy, Gastrointestinal. Female. Humans. Iopamidol / analogs & derivatives. Male. Middle Aged. Predictive Value of Tests. Prospective Studies. Reference Standards. Sensitivity and Specificity

MedlinePlus Health Information. consumer health - CT Scans.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] (c) RSNA, 2006.

(PMID = 17053201.001).

[ISSN] 0033-8419

[Journal-full-title] Radiology

[ISO-abbreviation] Radiology

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Contrast Media; 17E17JBP8L / iomeprol; JR13W81H44 / Iopamidol

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Comparison of magnetic resonance enterography and video capsule endoscopy in evaluating small bowel disease.

PURPOSE: The goal of this study was to compare magnetic resonance enterography (MRE) and video capsule endoscopy (VCE) in suspected small bowel disease.

MATERIALS AND METHODS: Nineteen patients with suspected small bowel disease participated in a prospective clinical comparison of MRE versus VCE.

RESULTS: Small bowel pathologies were found in 15 out of 19 patients: Crohn's disease (n= 5), lymphoma (n= 4), lymphangioma (n= 1), adenocarcinoma (n= 1), postradiation enteropathy (n= 1), NSAID-induced enteropathy (n =1), angiodysplasia (n= 1), and small bowel adhesions (n= 1).

MRE revealed 19 extraenteric findings in 11 patients as well as small bowel adhesions not detected on VCE (n= 1).

Thus, VCE and MRE appear to be complementary methods which, when used in conjunction, may better characterize suspected small bowel disease.

[MeSH-major] Capsule Endoscopy. Intestinal Diseases / diagnosis. Intestine, Small. Magnetic Resonance Imaging / methods

MedlinePlus Health Information. consumer health - MRI Scans.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19086147.001).

[ISSN] 1473-5687

[Journal-full-title] European journal of gastroenterology & hepatology

[ISO-abbreviation] Eur J Gastroenterol Hepatol

[Language] eng

[Publication-type] Comparative Study; Evaluation Studies; Journal Article

[Publication-country] England

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Adenocarcinoma of small intestinal type in retroperitoneal mature teratoma.

We report a case of small intestinal type adenocarcinoma arising in retroperitoneal mature cystic teratoma in a young male.

Adenocarcinoma without stromal invasion was observed adjacent to the small intestinal mucosa.

Immunohistochemistry of the adenocarcinoma tissue revealed p53 overexpression and high Ki-67 labeling index as well as positive staining for CD10, cytokeratin 7, and cytokeratin 20.

Therefore, the diagnosis of small intestinal adenocarcinoma was made.

To our knowledge, this is the first case of small intestinal adenocarcinoma arising in retroperitoneal mature cystic teratoma.

A unique feature of this case is that malignant transformation in retroperitoneal mature teratoma arose even in the fully developed intestine.

[MeSH-major] Adenocarcinoma / pathology. Neoplasms, Multiple Primary / pathology. Retroperitoneal Neoplasms / pathology. Teratoma / pathology

Genetic Alliance. consumer health - Teratoma.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] © 2010 The Authors. Pathology International © 2010 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

[ErratumIn] Pathol Int. 2010 Dec;60(12):798

(PMID = 20846270.001).

[ISSN] 1440-1827

[Journal-full-title] Pathology international

[ISO-abbreviation] Pathol. Int.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Australia

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Preoperative diagnosis of jejunal adenocarcinoma--a case report.

We report herein the case of a preoperatively diagnosed small bowel adenocarcinoma.

An US-guided fine (20 gauge) needle aspiration (FNA) cytology of the mass was performed and showed moderately differentiated adenocarcinoma of intestinal origin.

On surgical exploration a jejunal tumor of high consistency was found, located 15 cm distantly from the Treitz ligament, infiltrating up to 2/3 of the bowel circumference and partly obstructing its lumen.

The histological evaluation of the resected material showed highly to moderately differentiated adenocarcinoma with 5 regional lymph node metastases.

The combination of US with Doppler and FNA established preoperatively the malignant small bowel disease.

[MeSH-major] Adenocarcinoma / diagnosis. Jejunal Neoplasms / diagnosis

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18404799.001).

[ISSN] 1107-0625

[Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology

[ISO-abbreviation] J BUON

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Greece

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Obstructed small bowel ruptured toward the inguinal canal resulting from metastatic colon carcinoma in an irreducible, recurrent inguinal hernia with mesh-plug repair: Report of a case.

Delayed surgical exploration revealed metastatic cancer with small bowel adhesion to the mesh-plug and perforation.

The mesh-plug with adherent tissue was removed through the inguinal incision, and the ruptured small bowel was resected.

Histopathology revealed moderately differentiated mucinous adenocarcinoma of the tissue adhering to the prosthetic material corresponding to the original colon cancer.

[MeSH-major] Adenocarcinoma / secondary. Hernia, Inguinal / surgery. Intestinal Obstruction / pathology. Intestine, Small / surgery. Sigmoid Neoplasms / pathology

MedlinePlus Health Information. consumer health - Intestinal Obstruction.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.

(PMID = 20138732.001).

[ISSN] 1532-2157

[Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

[ISO-abbreviation] Eur J Surg Oncol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] England

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

A 72-year-old man was given a diagnosis of Crohn's disease in 1976 at age 44, and partial resection of is ileum was performed.

Ileocecal resection, partial resection of is small intestine and loop sigmoid colostomy were performed.

Endoscopic examination showed a fistula orifice in the rectum and biopsy of the fistula revealed mucinous adenocarcinoma.

[MeSH-major] Adenocarcinoma, Mucinous / etiology. Crohn Disease / complications. Ileal Diseases / complications. Intestinal Fistula / complications. Rectal Fistula / complications. Rectal Neoplasms / etiology

Genetic Alliance. consumer health - Crohn Disease.

MedlinePlus Health Information. consumer health - Crohn's Disease.

MedlinePlus Health Information. consumer health - Small Intestine Disorders.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17917397.001).

[ISSN] 0446-6586

[Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

[ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article; Review

[Publication-country] Japan

[Number-of-references] 12

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

The aim of the present review was to summarize the current evidence on the role of ultrasonography (US) and doppler-US in the diagnosis of celiac disease.

Firstly, case control studies identified some of these US signs and then in a prospective series some of these parameters, due to their high specificity, have been shown to be of value in confirming CD diagnosis, whereas others, due to their high sensitivity, have been demonstrated to be useful in excluding the presence of the disease.

The last part of this review will deal with the possible role of US in identifying the most severe and common intestinal complication of CD, i.e. the enteropathy-associated T cell non-Hodgkin lymphoma.

[MeSH-minor] Abdomen / blood supply. Abdomen / ultrasonography. Adenocarcinoma / diagnosis. Adenocarcinoma / ultrasonography. Algorithms. Case-Control Studies. Humans. Intestinal Neoplasms / ultrasonography. Intestine, Small / ultrasonography. Lymphoma, Non-Hodgkin / ultrasonography. Prospective Studies. Splanchnic Circulation. Ultrasonography. Ultrasonography, Doppler / methods

Genetic Alliance. consumer health - Celiac Disease.

MedlinePlus Health Information. consumer health - Celiac Disease.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] N Engl J Med. 2002 Jan 17;346(3):180-8 [11796853.001]

[Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S79-86 [15825131.001]

[Cites] Dig Liver Dis. 2003 Apr;35(4):262-8 [12801038.001]

[Cites] Arch Intern Med. 2004 Jan 26;164(2):169-74 [14744840.001]

[Cites] Gut. 1976 Aug;17(8):612-9 [789184.001]

[Cites] Lancet. 1983 Jan 15;1(8316):111-5 [6129425.001]

[Cites] Gastroenterology. 1989 Aug;97(2):265-71 [2744350.001]

[Cites] Br J Radiol. 1994 Nov;67(803):1139-40 [7820411.001]

[Cites] Ultraschall Med. 1996 Feb;17(1):31-3 [8650520.001]

[Cites] Gut. 1996 Sep;39(3):369-73 [8949639.001]

[Cites] Clin Radiol. 1997 Mar;52(3):244-5 [9091265.001]

[Cites] J Ultrasound Med. 1997 Feb;16(2):85-91; quiz 93-4 [9166799.001]

[Cites] AJR Am J Roentgenol. 1998 Sep;171(3):629-32 [9725286.001]

[Cites] J Pediatr Gastroenterol Nutr. 1998 Oct;27(4):444-5 [9779975.001]

[Cites] BMJ. 1999 Jan 16;318(7177):164-7 [9888912.001]

[Cites] Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B183-9 [11449160.001]

[Cites] Radiology. 1999 May;211(2):389-94 [10228518.001]

[Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S38-46 [15825125.001]

[Cites] Gastroenterology. 2005 Apr;128(4 Suppl 1):S47-51 [15825126.001]

[Cites] BMJ. 2002 Mar 2;324(7336):539-41 [11872558.001]

(PMID = 16534837.001).

[ISSN] 1007-9327

[Journal-full-title] World journal of gastroenterology

[ISO-abbreviation] World J. Gastroenterol.

[Language] eng

[Publication-type] Journal Article; Review

[Publication-country] China

[Number-of-references] 20

[Other-IDs] NLM/ PMC4087888

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.

The site-specific function of multidrug-resistance-associated proteins (MRPs), especially MRP2 and MRP3, was examined in rat intestine and human colon adenocarcinoma (Caco-2) cells.

In contrast, probenecid significantly suppressed both apical and basolateral efflux of DNP-SG in Caco2 cells, though the inhibition was of small magnitude.

In conclusion, the efflux of DNP-SG from enterocytes mediated by MRPs exhibited a significant regional difference in rat intestine, indicating possible variability in intestinal bioavailabilities of MRP substrates, depending on their absorption sites along the intestine.

[MeSH-major] Glutathione / analogs & derivatives. Intestinal Absorption. Membrane Transport Proteins / metabolism. Multidrug Resistance-Associated Proteins / metabolism

[MeSH-minor] Animals. Bile / metabolism. Biological Availability. Biological Transport. Blotting, Western. Caco-2 Cells. Dinitrochlorobenzene. Humans. Ileum / metabolism. Intestinal Mucosa / metabolism. Jejunum / metabolism. Male. Probenecid. Rats. Rats, Sprague-Dawley. Substrate Specificity

Hazardous Substances Data Bank. PROBENECID .

Hazardous Substances Data Bank. 1-CHLORO-2,4-DINITROBENZENE .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17430634.001).

[ISSN] 0022-3573

[Journal-full-title] The Journal of pharmacy and pharmacology

[ISO-abbreviation] J. Pharm. Pharmacol.

[Language] eng

[Publication-type] Journal Article

[Publication-country] England

[Chemical-registry-number] 0 / Membrane Transport Proteins; 0 / Multidrug Resistance-Associated Proteins; 0 / multidrug resistance-associated protein 2; 0 / multidrug resistance-associated protein 3; 26289-39-4 / S-(2,4-dinitrophenyl)glutathione; GAN16C9B8O / Glutathione; GE3IBT7BMN / Dinitrochlorobenzene; PO572Z7917 / Probenecid

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] No association of primary adenocarcinomas of the small bowel with Epstein-Barr virus infection.

Adenocarcinomas of the small bowel comprise a very rare entity, with little knowledge about molecular properties and etiological aspects.

We have investigated the prevalence of EBER expression (EBV-encoded small RNAs) in a series of small bowel adenocarcinomas (n=56) utilizing RNA in situ hybridization (EBER-RISH).

A surgical series of 82 primary resected gastric (n=36) or cardiac (n=46) adenocarcinomas (TU Munich) was used as control group.

None of the 56 small bowel carcinomas exhibited EBER expression whereas in the control group the rate of EBER expression accounted for 4.4% in the group of cardia carcinomas and 8.6% in the group of gastric cancers.

These results indicate that EBV infection plays no etiologic role in primary small bowel adenocarcinomas.

[MeSH-major] Adenocarcinoma / virology. Epstein-Barr Virus Infections / virology. Herpesvirus 4, Human / genetics. Intestinal Neoplasms / virology. Intestine, Small / virology. Stomach Neoplasms / virology

MedlinePlus Health Information. consumer health - Stomach Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] (c) 2006 Wiley-Liss, Inc.

(PMID = 16493667.001).

[ISSN] 0899-1987

[Journal-full-title] Molecular carcinogenesis

[ISO-abbreviation] Mol. Carcinog.

[Language] eng

[Publication-type] Journal Article; Multicenter Study

[Publication-country] United States

[Chemical-registry-number] 0 / RNA, Viral

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Barrett's metaplasia describes the development of a columnar/intestinal phenotype in the squamous oesophageal epithelium and is the major risk factor for oesophageal adenocarcinoma.

The homoeotic transcription factor Cdx2 (Caudal-type homeobox 2) has been implicated as a master switch gene for intestine and therefore for Barrett's metaplasia.

Normally, Cdx2 expression is restricted to the epithelium of the small and large intestine.

Loss of Cdx2 function, or conditional deletion in the intestine, results in replacement of intestinal cells with a stratified squamous phenotype.

In addition, Cdx2 is sufficient to provoke intestinal metaplasia in the stomach.

[MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Animals. CDX2 Transcription Factor. Esophageal Neoplasms / genetics. Esophageal Neoplasms / pathology. Humans. Metaplasia / genetics. Models, Biological

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 20298184.001).

[ISSN] 1470-8752

[Journal-full-title] Biochemical Society transactions

[ISO-abbreviation] Biochem. Soc. Trans.

[Language] eng

[Grant] United Kingdom / Medical Research Council / / G0300415; United Kingdom / Cancer Research UK / /

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review

[Publication-country] England

[Chemical-registry-number] 0 / CDX2 Transcription Factor; 0 / CDX2 protein, human; 0 / Homeodomain Proteins

[Number-of-references] 72

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Primary adenocarcinoma of jejunum with obscure gastrointestinal bleeding].

[Transliterated title] Adenocarcinoma primitivo del digiuno ad esteriorizzazione con enterorragia.

A case of primary small bowel adenocarcinoma is reported because of the rarity of this malignancy.

[MeSH-major] Adenocarcinoma. Gastrointestinal Hemorrhage / etiology. Jejunal Neoplasms

[MeSH-minor] Capsule Endoscopy. Diagnosis, Differential. Female. Humans. Jejunum / pathology. Middle Aged. Occult Blood. Prognosis

MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17147051.001).

[ISSN] 0009-9074

[Journal-full-title] La Clinica terapeutica

[ISO-abbreviation] Clin Ter

[Language] ita

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Italy

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Jaw metastases from the gastrointestinal (GI) tract usually evolve from adenocarcinoma of the esophagus, colon, and rectum.

These tumors are thought to arise from Cajal cells in GI tract walls, essential for intestine motor function.

The small intestine harbors only 30% of GIST.

The patient was treated with imatinib but died 11 months after the diagnosis.

DISCUSSION: The prevalence of GIST is low but the true incidence may be higher because of under-diagnosis.

GIST should be included in the differential diagnosis of intramandibular tumor in patients with prior or current non-oral malignancy.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19010506.001).

[ISSN] 0035-1768

[Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale

[ISO-abbreviation] Rev Stomatol Chir Maxillofac

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] France

[Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.

BACKGROUND: Metastatic small bowel adenocarcinoma (SBA) has a poor prognosis.

The primary tumor site was the jejunum in 35 patients (43%), duodenum in 30 patients (38%), ileum in 6 patients (8%), and nonspecified small bowel in 9 patients (11%).

[MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Intestinal Neoplasms / drug therapy. Intestine, Small / pathology

COS Scholar Universe. author profiles.

Hazardous Substances Data Bank. PLATINUM COMPOUNDS .

Hazardous Substances Data Bank. FLUOROURACIL .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] (c) 2008 American Cancer Society.

(PMID = 18759326.001).

[ISSN] 0008-543X

[Journal-full-title] Cancer

[ISO-abbreviation] Cancer

[Language] eng

[Grant] United States / NCI NIH HHS / CA / P30 CA016672

[Publication-type] Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Platinum Compounds; U3P01618RT / Fluorouracil

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Intestinal neurofibromatosis and small-bowel adenocarcinoma: a single case study.

However, the coexistence of neurofibromatosis with small-bowel adenocarcinoma is exceedingly rare.

We present an uncommon case of neurofibromatosis type 1, involving the small bowel in a 73-year-old man, who was admitted to our department with signs of acute abdomen.

These nodules obstructed ileal lumen, while the intestine wall was perforated in one point.

Histology revealed neurofibromatosis type 1 with malignant transformation to small-bowel adenocarcinoma.

We suggest that adenocarcinoma of small bowel should be considered in the evaluation of acute abdominal pain in neurofibromatosis patients.

[MeSH-major] Adenocarcinoma / pathology. Ileal Neoplasms / pathology. Intestine, Small / pathology. Neoplasms, Multiple Primary / pathology. Neurofibromatosis 1 / pathology

[MeSH-minor] Abdomen, Acute / etiology. Aged. Follow-Up Studies. Humans. Intestinal Obstruction / etiology. Intestinal Obstruction / pathology. Male. Tomography, X-Ray Computed

Genetic Alliance. consumer health - Neurofibromatosis.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19473375.001).

[ISSN] 1365-2354

[Journal-full-title] European journal of cancer care

[ISO-abbreviation] Eur J Cancer Care (Engl)

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] England

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Coeliac disease may have an ancient history dating back to the 1st and 2nd centuries AD.

Dicke's colleagues, Weijers and Van de Kamer, showed that measurement of stool fat reflected the clinical condition.

Histological abnormalities of the lining of the small intestine were demonstrated beyond doubt by Paulley in 1954 and techniques of per-oral biopsy described by Royer in 1955 and Shiner in 1956 afforded reliable diagnosis.

Lymphoma, adenocarcinoma and ulceration of the small intestine and a range of immunological disorders are associated.

[MeSH-minor] Dermatitis Herpetiformis / etiology. Dermatitis Herpetiformis / history. History, 19th Century. History, 20th Century. History, Ancient. Humans. Intestinal Neoplasms / etiology. Intestinal Neoplasms / history. Intestine, Small / pathology. Lymphoma / etiology. Lymphoma / history. Transglutaminases / metabolism. Ulcer / etiology. Ulcer / history

MedlinePlus Health Information. consumer health - Celiac Disease.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] 2008 S. Karger AG, Basel.

(PMID = 18431060.001).

[ISSN] 1421-9875

[Journal-full-title] Digestive diseases (Basel, Switzerland)

[ISO-abbreviation] Dig Dis

[Language] eng

[Publication-type] Historical Article; Journal Article; Review

[Publication-country] Switzerland

[Chemical-registry-number] EC 2.3.2.13 / Transglutaminases

[Number-of-references] 96

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease.

Small intestinal biopsy and bone mineral density were investigated in 2001 and clinical features were followed up until 2005.

RESULTS: Thirteen coeliac patients had persistent small intestinal villous atrophy despite maintaining gluten-free diet.

In 2005, two of the non-responders had developed symptomatic refractory sprue, one died of lymphoma and one of carcinoid tumour, and one gastric adenocarcinoma was operated.

[MeSH-major] Celiac Disease / diet therapy. Intestine, Small / pathology. Lymphoma / etiology

[MeSH-minor] Adult. Aged. Atrophy. Female. Humans. Intestinal Mucosa / pathology. Middle Aged. Patient Care

MedlinePlus Health Information. consumer health - Celiac Disease.

MedlinePlus Health Information. consumer health - Lymphoma.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17451570.001).

[ISSN] 0269-2813

[Journal-full-title] Alimentary pharmacology & therapeutics

[ISO-abbreviation] Aliment. Pharmacol. Ther.

[Language] eng

[Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

[Publication-country] England

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [A case report of primary adenocarcinoma of small intestine].

This is an account of a case of primary adenocarcinoma of the small intestine with peritoneal dissemination successfully treated with chemotherapy.

Abdominal computerized tomography revealed a bowel obstruction with tumor and the remarkable small bowel dilation of oral side of tumor.

Pathological diagnosis of the resected specimen was adenocarcinoma with lymph nodes metastasis.

The peritoneal dissemination consisted of metastatic adenocarcinoma from small intestine.

Primary small intestinal adenocarcinoma is a rare disease, and it is often diagnosed as advanced cancer because of few characteristic symptoms.

So carcinoma of the small intestine usually has a poor prognosis.

[MeSH-major] Adenocarcinoma / therapy. Intestinal Neoplasms / therapy

Hazardous Substances Data Bank. FLUOROURACIL .

Hazardous Substances Data Bank. LEUCOVORIN .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 21224715.001).

[ISSN] 0385-0684

[Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy

[ISO-abbreviation] Gan To Kagaku Ryoho

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

[Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antimetabolites, Antineoplastic; 0 / Drug Combinations; 0 / Organoplatinum Compounds; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 2S9ZZM9Q9V / Bevacizumab; 5VT6420TIG / Oxonic Acid; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Primary small bowel adenocarcinoma].

[Transliterated title] Adenocarcinoma primario de intestino delgado.

INTRODUCTION: Primary small bowel adenocarcinoma is an uncommon tumour, with non-specific symptoms that cause a delay in the diagnosis and consequently a worse outcome for the patient.

MATERIAL AND METHOD: We performed a retrospective study of our experience with 17 patients diagnosed with primary small bowel adenocarcinoma, excluding all the cases suggesting secondary involvement of the small bowel from an adenocarcinoma in other locations.

Those with duodenal tumours underwent 4 pancreaticoduodenectomies, 3 gastroenterostomies and 1 diagnostic biopsy; 6 bowel resections with lymphadenectomy, 2 en-bloc resections and 1 by-pass were performed on those with jejuno-ileal tumours.

CONCLUSIONS: Curative treatment consists of small bowel resection.

[MeSH-major] Adenocarcinoma. Duodenal Neoplasms. Ileal Neoplasms. Jejunal Neoplasms

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19344893.001).

[ISSN] 0009-739X

[Journal-full-title] Cirugía española

[ISO-abbreviation] Cir Esp

[Language] spa

[Publication-type] English Abstract; Journal Article

[Publication-country] Spain

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Basopholic intracytoplasmic viral matrix inclusions (MIs) were widely distributed in the chickens affected with subcutaneous myxoma rhabdomyosarcoma, perineuroma, glioma, intra-abdominal adenocarcinoma, and nephroblastoma.

They were also present in the smooth muscle cells of the arteries in the spleen and lungs, in the smooth muscle of the digestive tract muscular layer (crop, oesophagus, proventriculus, gizzard, duodenum, jejunum, ileum, caecum, and large intestine), and in the smooth muscle of the capsule in the ovary and pancreas.

They consisted of electron-dense small granules and ring-shaped particles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17364510.001).

[ISSN] 0307-9457

[Journal-full-title] Avian pathology : journal of the W.V.P.A

[ISO-abbreviation] Avian Pathol.

[Language] eng

[Publication-type] Journal Article

[Publication-country] England

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

We also determined the protective effects of single large and multiple small doses of palifermin.

Tumor-bearing DA rats were treated with a single large (10 mg/kg) dose of palifermin 3 days prior to, or multiple small (3 mg/kg day for 3 days) doses of palifermin or vehicle control prior to, receiving 2 doses of 150 mg/kg irinotecan.

Small and large intestinal weights were maintained.

Intestinal morphometry was not maintained in palifermin-pretreated rats despite being increased prior to irinotecan treatment.

Palifermin pretreatment did not prevent apoptosis that peaked at 6 hr in the jejunum or colon, but prevented apoptosis at 96 hr in the small intestine.

[MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / veterinary. Animals. Female. Fibroblast Growth Factor 7. Keratinocytes. Mammary Neoplasms, Animal / drug therapy. Rats. Survival Analysis

MedlinePlus Health Information. consumer health - Diarrhea.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15800945.001).

[ISSN] 0020-7136

[Journal-full-title] International journal of cancer

[ISO-abbreviation] Int. J. Cancer

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Fgf7 protein, rat; 126469-10-1 / Fibroblast Growth Factor 7; 62031-54-3 / Fibroblast Growth Factors; 7673326042 / irinotecan; XT3Z54Z28A / Camptothecin

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

In vivo imaging could greatly facilitate these trials, but the small size of the animals is a major limitation for the direct visualization of intestinal tissue.

Here we report a method of in vivo imaging of the mouse intestine based on X-ray micro-computed tomography using multiple contrast agents.

This method was validated in the model of non-cancerous polyp-like heteroplasia that spontaneously develops in the caecum area of Cdx2+/- mutant mice and in the model of colon adenocarcinoma induced by administration of the chemical carcinogen azoxymethane.

As a simple and non-invasive method, multiple-contrast X-ray micro-computed tomography is appropriate for pre-clinical studies of intestinal diseases in living mice.

[MeSH-minor] Animals. Equipment Design. Heterozygote. Homeodomain Proteins / genetics. Intestinal Diseases / radiography. Male. Mice. Mice, Knockout. Transcription Factors / deficiency. Transcription Factors / genetics

MedlinePlus Health Information. consumer health - CT Scans.

Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17923376.001).

[ISSN] 1631-0691

[Journal-full-title] Comptes rendus biologies

[ISO-abbreviation] C. R. Biol.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] France

[Chemical-registry-number] 0 / Cdx2 protein, mouse; 0 / Homeodomain Proteins; 0 / Transcription Factors

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Unconfirmed partial responses were observed in two patients, one with metastatic small bowel adenocarcinoma and the other with metastatic esophageal cancer.

MedlinePlus Health Information. consumer health - Cancer Chemotherapy.

MedlinePlus Health Information. consumer health - Lymphoma.

COS Scholar Universe. author profiles.

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16278410.001).

[ISSN] 1078-0432

[Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research

[ISO-abbreviation] Clin. Cancer Res.

[Language] eng

[Grant] United States / NCRR NIH HHS / RR / M01 RR00032

[Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural

[Publication-country] United States

[Chemical-registry-number] 0 / Antineoplastic Agents; 30IQX730WE / Polyethylene Glycols; 581079-18-7 / pegamotecan; XT3Z54Z28A / Camptothecin

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Adenocarcinoma of the small intestines complicating coeliac disease in an adult: case report].

[Transliterated title] Adénocarcinome de l'intestin grêle compliquant une maladie coeliaque de l'adulte: à propos d'un cas.

This small bowel adenocarcinoma is rare and concerns less than 5% of the digestive neoplasias.

We are reporting the case of a 67-years-old woman whose coeliac disease has been complicated 5 years thereafter by a jejunal adenocarcinoma.

[MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / diagnosis. Celiac Disease / complications. Incidental Findings. Jejunal Neoplasms / complications. Jejunal Neoplasms / diagnosis

MedlinePlus Health Information. consumer health - Celiac Disease.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19777919.001).

[ISSN] 0370-629X

[Journal-full-title] Revue médicale de Liège

[ISO-abbreviation] Rev Med Liege

[Language] fre

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Belgium

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.

Cadherin-17, also called liver-intestine cadherin, is a calcium-dependent transmembrane glycoprotein that mediates cell-cell adhesion in intestinal epithelium.

Expression of cadherin-17 was reported in gastric, pancreatic, and colorectal adenocarcinomas but not in other tumors.

Whether cadherin-17 can be used as a marker for diagnosis of cancers is still unclear.

Among normal tissues, the expression of cadherin-17 was limited to epithelial cells of small intestine and colon.

Colorectal adenocarcinomas showed staining in 96% of cases and most of them had strong and diffuse staining.

Gastric, pancreatic, and biliary adenocarcinomas showed diffuse or scattered staining in about 25-50% of cases.

When a two-marker, Cadherin-17/cytokeratin 7, profile was used, 37 of 38 (97%) cadherin-17(+)/cytokeratin 7(-) tumors were colorectal adenocarcinomas; 49 of 56 (86%) cadherin-17(+)/cytokeratin 7(+) tumors were gastric, pancreatic, or biliary adenocarcinomas.

Our results show that cadherin-17 is a useful immunohistochemical marker for diagnosis of adenocarcinomas of the digestive system.

[MeSH-major] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Cadherins / analysis. Gastrointestinal Neoplasms / diagnosis

[MeSH-minor] Colorectal Neoplasms / chemistry. Colorectal Neoplasms / diagnosis. Female. Humans. Immunoenzyme Techniques. Male. Pancreatic Neoplasms / chemistry. Pancreatic Neoplasms / diagnosis. Stomach Neoplasms / chemistry. Stomach Neoplasms / diagnosis

COS Scholar Universe. author profiles.

The Lens. Cited by Patents in .

antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18552820.001).

[ISSN] 1530-0285

[Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

[ISO-abbreviation] Mod. Pathol.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDH17 protein, human; 0 / Cadherins

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.

BACKGROUND: Hepatocyte growth factor activator inhibitor type 2-related small peptide (H2RSP) is a small nuclear protein abundantly expressed in the gastrointestinal epithelium.

AIMS: To investigate the expression and localisation of H2RSP in normal, injured and neoplastic human intestinal tissue.

METHODS: Immunohistochemical examination and in situ hybridisation for H2RSP were performed using normal and diseased intestinal specimens.

RESULTS: In the normal intestine, H2RSP was observed in the nuclei of surface epithelial cells and this nuclear localisation was impaired in regenerating epithelium.

H2RSP expression was down regulated in well-differentiated colorectal adenocarcinomas.

The number of H2RSP-positive cells in the invasive front of well-differentiated adenocarcinomas was considerably higher in the cases with lymph node metastases than in node-negative ones.

CONCLUSION: In the normal intestine, the nuclear accumulation of H2RSP is a marker of differentiated epithelial cells.

Although H2RSP was down regulated in colorectal adenocarcinomas, a paradoxical up regulation was observed in actively invading carcinoma cells.

[MeSH-major] Adenocarcinoma / chemistry. Colonic Neoplasms / chemistry. Neoplasm Proteins / analysis. Nuclear Proteins / analysis. Transcription Factors / analysis

[MeSH-minor] Adenoma / chemistry. Adenoma / immunology. Adenoma / pathology. Animals. CHO Cells. Cell Count. Cell Differentiation / physiology. Cell Division / physiology. Cell Line, Tumor. Colitis, Ulcerative / immunology. Colitis, Ulcerative / pathology. Colorectal Neoplasms / chemistry. Colorectal Neoplasms / immunology. Colorectal Neoplasms / pathology. Cricetinae. Cricetulus. Epithelial Cells / chemistry. Epithelial Cells / immunology. Epithelial Cells / pathology. Humans. Hyperplasia. Immunohistochemistry / methods. In Situ Hybridization / methods. Intestinal Polyps / chemistry. Intestinal Polyps / immunology. Intestinal Polyps / pathology. Intestines / chemistry. Intestines / immunology. Intestines / pathology. Lymphatic Metastasis. Neoplasm Invasiveness. beta Catenin / analysis

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Oncogene. 2001 Sep 6;20(39):5475-83 [11571645.001]

[Cites] J Biol Chem. 2001 May 25;276(21):18352-60 [11278568.001]

[Cites] Am J Pathol. 2001 Nov;159(5):1613-7 [11696421.001]

[Cites] Bioessays. 2002 Jan;24(1):91-8 [11782954.001]

[Cites] J Cell Sci. 2002 Apr 1;115(Pt 7):1355-9 [11896183.001]

[Cites] Cancer Res. 2002 Aug 15;62(16):4791-804 [12183439.001]

[Cites] Cell. 2002 Oct 18;111(2):241-50 [12408868.001]

[Cites] Cell. 2002 Oct 18;111(2):251-63 [12408869.001]

[Cites] Biochem Biophys Res Commun. 2003 Mar 7;302(2):345-53 [12604353.001]

[Cites] Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):223-36 [12784998.001]

[Cites] Anticancer Res. 2003 Nov-Dec;23(6C):4709-13 [14981917.001]

[Cites] J Cell Physiol. 2004 May;199(2):262-73 [15040009.001]

[Cites] Clin Cancer Res. 2004 Apr 15;10(8):2790-6 [15102686.001]

[Cites] Cancer Sci. 2004 Sep;95(9):728-35 [15471558.001]

[Cites] Am J Anat. 1974 Dec;141(4):537-61 [4440635.001]

[Cites] J Cell Biol. 1989 Apr;108(4):1187-94 [2647764.001]

[Cites] Development. 1990 Dec;110(4):1001-20 [2100251.001]

[Cites] J Biol Chem. 1997 Oct 31;272(44):27558-64 [9346890.001]

[Cites] Am J Pathol. 1998 Aug;153(2):341-7 [9708793.001]

[Cites] Front Biosci. 1999 Mar 15;4:D286-98 [10077541.001]

[Cites] J Biol Chem. 1999 May 28;274(22):15908-12 [10336496.001]

[Cites] Gastroenterology. 2004 Nov;127(5):1423-35 [15521012.001]

[Cites] J Cell Biol. 2005 Feb 14;168(4):633-42 [15716380.001]

[Cites] Virchows Arch. 2006 Mar;448(3):354-60 [16189703.001]

[Cites] J Biol Chem. 1999 Dec 17;274(51):36513-9 [10593949.001]

[Cites] Carcinogenesis. 2000 Mar;21(3):469-76 [10688867.001]

[Cites] Eur J Biochem. 2000 Jun;267(11):3351-9 [10824123.001]

[Cites] J Clin Invest. 2000 Jun;105(11):1493-9 [10841502.001]

[Cites] Gene. 2000 Oct 31;257(2):327-34 [11080599.001]

[Cites] Mech Dev. 2001 Mar;101(1-2):3-9 [11231054.001]

[Cites] Biochem Biophys Res Commun. 2001 Oct 26;288(2):390-9 [11606055.001]

(PMID = 16809422.001).

[ISSN] 0017-5749

[Journal-full-title] Gut

[ISO-abbreviation] Gut

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] England

[Chemical-registry-number] 0 / C19orf33 protein, human; 0 / Neoplasm Proteins; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / beta Catenin

[Other-IDs] NLM/ PMC1856747

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [A case of jejunal adenocarcinoma with serum DUPAN-2 elevation].

Ileus with ulcerated jejunal tumor was diagnosed and biopsy revealed adenocarcinoma.

Surgical resection was performed: both tumors were adenocarcinoma, but the ovarian tumor was considered to be metastatic clinically and histologically.

This case shows a possible relation between small bowel adenocarcinoma and DUPAN-2.

[MeSH-major] Adenocarcinoma / diagnosis. Antigens, Neoplasm / blood. Jejunal Neoplasms / diagnosis

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 21071898.001).

[ISSN] 0446-6586

[Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

[ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

[Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / DU-PAN-2 antigen, human

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

The most common localization is the small intestine.

We report on a 94-year-old man with gastric PI associated with inoperable adenocarcinoma localized in the duodenum.

We suggest that in patients presenting with PI, malignancy should be considered in the differential diagnosis.

[MeSH-major] Adenocarcinoma / diagnosis. Duodenal Neoplasms / diagnosis. Pneumatosis Cystoides Intestinalis / diagnosis. Pneumatosis Cystoides Intestinalis / radiography

[MeSH-minor] Aged, 80 and over. Blood Proteins / analysis. Blood Proteins / isolation & purification. Diagnosis, Differential. Fatal Outcome. Humans. Male. Stomach Diseases / diagnosis. Stomach Diseases / etiology. Stomach Diseases / radiography. Tomography, X-Ray Computed. Urine / cytology

MedlinePlus Health Information. consumer health - Intestinal Cancer.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Pediatr Radiol. 2001 Sep;31(9):656-8 [11512009.001]

[Cites] Am J Gastroenterol. 1999 Sep;94(9):2560-1 [10484028.001]

[Cites] Neth J Med. 2002 Mar;60(1):22-5 [12074039.001]

[Cites] J Paediatr Child Health. 2003 Sep-Oct;39(7):560-2 [12969216.001]

[Cites] Arch Dis Child. 1976 May;51(5):395-8 [938084.001]

[Cites] Acta Hepatogastroenterol (Stuttg). 1979 Oct;26(5):419-22 [525221.001]

[Cites] South Med J. 1986 Jan;79(1):79-80 [2418509.001]

[Cites] Pediatr Radiol. 1987;17(3):262 [2954025.001]

[Cites] Ann Surg. 1990 Aug;212(2):160-5 [2375647.001]

[Cites] Dis Colon Rectum. 1991 Jan;34(1):94-6 [1991429.001]

[Cites] Dig Dis Sci. 1992 Jun;37(6):949-54 [1587203.001]

[Cites] J Med. 1992;23(3-4):279-88 [1479305.001]

[Cites] Am J Gastroenterol. 1995 Oct;90(10):1747-58 [7572888.001]

[Cites] Int J Colorectal Dis. 1996;11(3):111-8 [8811375.001]

[Cites] Undersea Hyperb Med. 1996 Jun;23(2):115-7 [8840480.001]

[Cites] Dig Dis Sci. 1996 Nov;41(11):2272-85 [8943984.001]

[Cites] Am J Gastroenterol. 1997 Apr;92(4):692-5 [9128327.001]

[Cites] Acta Medica (Hradec Kralove). 2001;44(3):89-92 [11811082.001]

(PMID = 19222105.001).

[ISSN] 2219-2840

[Journal-full-title] World journal of gastroenterology

[ISO-abbreviation] World J. Gastroenterol.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] China

[Chemical-registry-number] 0 / Blood Proteins

[Other-IDs] NLM/ PMC2653449

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

As a consequence of the injury, the villi and crypt structures of the small intestine disappeared, leading to profuse bleeding and death.

In both cases, lethal and sub-lethal doses, the target of nigrin b appeared to be the highly proliferating stem cells of the intestinal crypts, which had undergone apoptotic changes.

Nigrin b killed COLO 320 human colon adenocarcinoma cells with an IC(50) of 3.1 x 10(-8) M and the effect was parallel to the extent of DNA fragmentation of these cells.

Accordingly, despite the low general toxicity exerted by nigrin b as compared with ricin, intravenous injection of large amounts of nigrin b is able to kill mouse intestinal stem cells without threatening the lives of the animals, thereby opening a door for its use for the targeting of intestinal stem cells.

[MeSH-major] Intestine, Small / drug effects. N-Glycosyl Hydrolases / toxicity. Plant Proteins / toxicity

Hazardous Substances Data Bank. RICIN .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16102565.001).

[ISSN] 0041-008X

[Journal-full-title] Toxicology and applied pharmacology

[ISO-abbreviation] Toxicol. Appl. Pharmacol.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Plant Proteins; 0 / Ribosome Inactivating Proteins, Type 2; 9009-86-3 / Ricin; EC 3.2.2.- / N-Glycosyl Hydrolases

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

METHODS AND MATERIALS: Between December 1996 and January 2002, 27 patients with prostate adenocarcinoma were treated with conformal WPRT as part of their definitive treatment.

Dose-volume histograms for the bowel, bladder, and rectum were compared for the three techniques.

RESULTS: Three-dimensional-CRT resulted in a 40% relative reduction (p < 0.001) in the volume of bowel receiving 45 Gy compared with 2D, and IMRT provided a further 60% reduction relative to 3D-CRT (p < 0.001).

CONCLUSIONS: Compared to conventional 2D planning, conformal planning for WPRT resulted in significant reductions in the doses delivered to the bowel, rectum, and bladder.

IMRT was superior to 3D-CRT in limiting the volume of bowel and rectum within high-dose regions.

[MeSH-minor] Adult. Aged. Aged, 80 and over. Colon / radiation effects. Diarrhea / etiology. Humans. Intestine, Small / radiation effects. Male. Middle Aged. Pelvis. Radiation Dosage. Radiotherapy, Intensity-Modulated / adverse effects. Radiotherapy, Intensity-Modulated / methods. Rectum / radiation effects. Urinary Bladder / radiation effects. Urination Disorders / etiology

Genetic Alliance. consumer health - Prostate cancer.

MedlinePlus Health Information. consumer health - Prostate Cancer.

COS Scholar Universe. author profiles.

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15913914.001).

[ISSN] 0360-3016

[Journal-full-title] International journal of radiation oncology, biology, physics

[ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.

BACKGROUND: Small bowel adenocarcinoma is a rare cancer that has generally been considered resistant to chemotherapy, although little has been published on the role of chemotherapy.

A retrospective analysis was conducted of patients with advanced small bowel adenocarcinoma to explore chemotherapy use, and gain knowledge for ongoing management and future clinical trials.

PATIENTS AND METHODS: All patients with advanced adenocarcinoma of the small bowel treated at Princess Margaret Hospital (PMH) between 1986 and 2004 were identified through the cancer registry.

CONCLUSION: Chemotherapy appears to have activity in adenocarcinoma of the small bowel.

[MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Intestinal Neoplasms / drug therapy. Intestinal Neoplasms / pathology

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16755174.001).

[ISSN] 1537-453X

[Journal-full-title] American journal of clinical oncology

[ISO-abbreviation] Am. J. Clin. Oncol.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

BACKGROUND: There is very small occurrence of adenocarcinoma in the small bowel.

We present a case of primary duodenal adenocarcinoma and discuss the findings of the case diagnostic modalities, current knowledge on the molecular biology behind small bowel neoplasms and treatment options.

CASE: The patient had a history of iron deficiency anemia and occult bleeding with extensive workup consisting of upper endoscopy, colonoscopy, capsule endoscopy, upper gastrointestinal series with small bowel follow through and push enteroscopy.

Due to persistent abdominal pain and iron deficiency anemia the patient underwent push enteroscopy which revealed adenocarcinoma of the duodenum.

The patient underwent en-bloc duodenectomy which revealed T3N1M0 adenocarcinoma of the 4th portion of the duodenum.

CONCLUSIONS: Primary duodenal carcinoma, although rare should be considered in the differential diagnosis of occult gastrointestinal bleeding when evaluation of the lower and upper GI tract is unremarkable.

We discuss the current evaluation and management of this small bowel neoplasm.

[MeSH-major] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Duodenal Neoplasms / diagnosis

[MeSH-minor] Aged. Diagnosis, Differential. Duodenoscopy. Female. Humans. Laparotomy. Ligaments. Tomography, X-Ray Computed

MedlinePlus Health Information. consumer health - Intestinal Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Dig Dis Sci. 2008 Aug;53(8):2140-3 [18270840.001]

[Cites] Gastrointest Endosc. 2008 May;67(6):890-7 [18178204.001]

[Cites] Clin Gastroenterol Hepatol. 2008 Nov;6(11):1202-5 [18799359.001]

[Cites] Gastrointest Endosc. 2008 Dec;68(6):1117-21 [19028219.001]

[Cites] Gastrointest Endosc. 2008 Dec;68(6):1209-14 [19028234.001]

[Cites] Ann Surg. 2009 Jan;249(1):63-71 [19106677.001]

[Cites] Gastrointest Endosc. 2009 Apr;69(4):866-74 [19136098.001]

[Cites] Pediatr Blood Cancer. 2009 Jul;53(1):116-20 [19283792.001]

[Cites] Gastrointest Endosc Clin N Am. 2009 Jul;19(3):349-56 [19647644.001]

[Cites] J Gastrointest Cancer. 2009;40(1-2):33-7 [19513860.001]

[Cites] World J Gastroenterol. 2009 Dec 28;15(48):6075-9 [20027680.001]

[Cites] Gastroenterology. 2000 Jan;118(1):201-21 [10611170.001]

[Cites] Am Surg. 2000 Jan;66(1):46-51 [10651347.001]

[Cites] Am J Surg. 2000 Jan;179(1):37-41 [10737576.001]

[Cites] Gastroenterology. 2000 Dec;119(6):1431-8 [11113063.001]

[Cites] J Clin Gastroenterol. 2001 Oct;33(4):267-82 [11588539.001]

[Cites] Gut. 2002 Feb;50(2):218-23 [11788563.001]

[Cites] Endoscopy. 2002 Sep;34(9):685-9 [12195324.001]

[Cites] Arch Surg. 2003 Jan;138(1):80-5 [12511157.001]

[Cites] QJM. 2003 May;96(5):345-53 [12702783.001]

[Cites] Isr Med Assoc J. 2003 Mar;5(3):188-92 [12725140.001]

[Cites] Endoscopy. 2003 Dec;35(12):1009-14 [14648412.001]

[Cites] Gut. 2004 Feb;53(2):261-5 [14724161.001]

[Cites] J Clin Oncol. 2004 Feb 1;22(3):493-8 [14752072.001]

[Cites] Chin Med J (Engl). 2004 Jul;117(7):1045-9 [15265380.001]

[Cites] Cancer. 2004 Aug 1;101(3):518-26 [15274064.001]

[Cites] Ann Surg. 1974 Aug;180(2):175-9 [4843046.001]

[Cites] Cancer. 1984 Jan 1;53(1):23-5 [6690001.001]

[Cites] Cancer Res. 1989 Sep 1;49(17):4682-9 [2547513.001]

[Cites] Dig Dis Sci. 1992 Aug;37(8):1179-84 [1499440.001]

[Cites] Cancer Causes Control. 1993 Mar;4(2):163-9 [8481495.001]

[Cites] Am J Gastroenterol. 1994 May;89(5):699-701 [8172140.001]

[Cites] Am J Gastroenterol. 1994 Dec;89(12):2139-42 [7977229.001]

[Cites] Br J Surg. 1994 Oct;81(10):1472-4 [7820475.001]

[Cites] Am Surg. 1995 Aug;61(8):698-702; discussion 702-3 [7618809.001]

[Cites] Cancer Genet Cytogenet. 1995 Jul 15;82(2):146-50 [7664244.001]

[Cites] Int J Cancer. 1997 Feb 7;70(4):390-5 [9033644.001]

[Cites] Ann Surg. 1997 Mar;225(3):300-6 [9060587.001]

[Cites] Oncology (Williston Park). 1997 Apr;11(4):529-36; discussion 545, 549-50 [9130275.001]

[Cites] AJR Am J Roentgenol. 1997 Dec;169(6):1545-50 [9393162.001]

[Cites] Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):243-51 [9521441.001]

[Cites] Br J Cancer. 1998 Aug;78(4):508-10 [9716035.001]

[Cites] Int J Cancer. 1999 Jul 19;82(2):171-4 [10389747.001]

[Cites] Am J Gastroenterol. 1999 Jul;94(7):1884-7 [10406253.001]

[Cites] Radiology. 2004 Nov;233(2):338-44 [15459329.001]

[Cites] Gastrointest Endosc. 2004 Nov;60(5):711-3 [15557946.001]

[Cites] J Clin Gastroenterol. 2005 Jan;39(1):36-41 [15599208.001]

[Cites] Cancer Causes Control. 2005 Sep;16(7):781-7 [16132788.001]

[Cites] Endoscopy. 2005 Oct;37(10):960-5 [16189768.001]

[Cites] World J Gastroenterol. 2006 Mar 21;12(11):1802-4 [16586559.001]

[Cites] Gastrointest Endosc Clin N Am. 2006 Apr;16(2):363-76 [16644464.001]

[Cites] Endoscopy. 2006 May;38(5):542 [16586243.001]

[Cites] Cancer. 2006 Jul 1;107(1):22-7 [16736516.001]

[Cites] Gastrointest Endosc. 2006 Sep;64(3):445-9 [16923502.001]

[Cites] Gastrointest Endosc. 2006 Nov;64(5):740-50 [17055868.001]

[Cites] Radiology. 2006 Dec;241(3):796-801 [17053201.001]

[Cites] Arch Surg. 2007 Mar;142(3):229-35 [17372046.001]

[Cites] Dig Dis Sci. 2007 Apr;52(4):1121-4 [17226074.001]

[Cites] Lancet. 2007 Jul 14;370(9582):114-6 [17630023.001]

[Cites] World J Gastroenterol. 2007 Aug 28;13(32):4372-8 [17708614.001]

[Cites] JAAPA. 2007 Sep;20(9):32-3, 35-6, 38 [17902540.001]

[Cites] Nat Clin Pract Gastroenterol Hepatol. 2008 Oct;5(10):569-82 [18797444.001]

(PMID = 20849628.001).

[ISSN] 1471-230X

[Journal-full-title] BMC gastroenterology

[ISO-abbreviation] BMC Gastroenterol

[Language] eng

[Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] England

[Chemical-registry-number] 0 / Biomarkers, Tumor

[Other-IDs] NLM/ PMC2949773

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].

[Transliterated title] Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer). Prédisposition héréditaire aux cancers du côlon, du rectum et de l'utérus.

Patients affected by the disease are at high risk for colorectal and endometrial carcinomas, but also for small intestine, urothelial, ovary, stomach and biliary tract carcinomas.

[MeSH-major] Adenocarcinoma / genetics. Colonic Neoplasms / genetics. Colorectal Neoplasms, Hereditary Nonpolyposis / genetics. Endometrial Neoplasms / genetics. Rectal Neoplasms / genetics

Genetic Alliance. consumer health - Colorectal Cancer.

Genetic Alliance. consumer health - Hereditary Cancer.

Genetic Alliance. consumer health - Lynch syndrome.

Genetic Alliance. consumer health - Non-Polyposis Colorectal Cancer.

Genetic Alliance. consumer health - Endometrial cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16677780.001).

[ISSN] 0369-8114

[Journal-full-title] Pathologie-biologie

[ISO-abbreviation] Pathol. Biol.

[Language] fre

[Publication-type] English Abstract; Journal Article; Review

[Publication-country] France

[Number-of-references] 97

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Intestinal occlusion resulting from a small bowel adenocarcinoma as first onset of Crohn's disease in a healthy patient.

[MeSH-major] Adenocarcinoma / pathology. Crohn Disease / etiology. Ileal Neoplasms / pathology. Intestinal Obstruction / etiology

Genetic Alliance. consumer health - Crohn Disease.

MedlinePlus Health Information. consumer health - Crohn's Disease.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

MedlinePlus Health Information. consumer health - Intestinal Obstruction.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19280822.001).

[ISSN] 0003-1348

[Journal-full-title] The American surgeon

[ISO-abbreviation] Am Surg

[Language] eng

[Publication-type] Case Reports; Letter

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway.

Celiac disease (CD) is an inflammatory disorder associated with an increased risk of small bowel adenocarcinoma.

We hypothesized that CIM may link CD to small bowel carcinogenesis.

We determined microsatellite instability (MSI), CIM, and expression of MLH1 and MGMT in 3 CD-associated small bowel carcinomas and corresponding non-neoplastic mucosa.

The results were compared to those of small bowel mucosa from CD patients without carcinoma and 20 small bowel carcinomas from a non-CD origin.

In conclusion, our data reveal that the high-level CIM/MSI pathway is typical of CD-associated small bowel carcinomas and indicate that aberrant CpG island methylation links CD and carcinogenesis.

The data further suggest that CD should be considered in patients with small bowel adenocarcinoma, particularly when the tumors display MSI.

[MeSH-major] Adenocarcinoma / genetics. Celiac Disease / genetics. CpG Islands. DNA Methylation. Intestinal Neoplasms / genetics. Microsatellite Instability

[MeSH-minor] Adaptor Proteins, Signal Transducing / genetics. Adult. Aged. Aged, 80 and over. Cohort Studies. DNA Modification Methylases / genetics. DNA Repair Enzymes / genetics. Disease Progression. Female. Gene Expression Regulation, Neoplastic. Humans. Intestinal Mucosa / metabolism. Intestinal Mucosa / pathology. Intestine, Small / metabolism. Intestine, Small / pathology. Male. Middle Aged. Nuclear Proteins / genetics. Signal Transduction / genetics. Tumor Suppressor Proteins / genetics

Genetic Alliance. consumer health - Celiac Disease.

MedlinePlus Health Information. consumer health - Celiac Disease.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 21042749.001).

[ISSN] 1791-2431

[Journal-full-title] Oncology reports

[ISO-abbreviation] Oncol. Rep.

[Language] eng

[Publication-type] Journal Article

[Publication-country] Greece

[Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / MLH1 protein, human; 0 / Nuclear Proteins; 0 / Tumor Suppressor Proteins; EC 2.1.1.- / DNA Modification Methylases; EC 2.1.1.63 / MGMT protein, human; EC 6.5.1.- / DNA Repair Enzymes

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] A case of small bowel adenocarcinoma in a patient with Crohn's disease detected by PET/CT and double-balloon enteroscopy.

Small bowel adenocarcinoma (SBA) in patients with Crohn's disease (CD) is quite rare, difficult to diagnose without surgery, and has a poor prognosis.

PET/CT detected an accumulation spot in the small bowel.

An endoscopic forceps biopsy specimen showed poorly differentiated adenocarcinoma.

There were some longitudinal ulcer scars near the tumor, and the chronic inflammation in the small bowel appeared to be associated with the cancer development.

Since early diagnosis is extremely difficult in these cases, novel techniques, such as PET/CT and DBE, may be expected to help in making a preoperative diagnosis of the development of SBA in CD.

[MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / etiology. Crohn Disease / complications. Endoscopy, Gastrointestinal / methods. Intestinal Neoplasms / diagnosis. Intestinal Neoplasms / etiology. Intestine, Small / pathology

Genetic Alliance. consumer health - Crohn Disease.

MedlinePlus Health Information. consumer health - Crohn's Disease.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Gut. 2001 Apr;48(4):526-35 [11247898.001]

[Cites] Cancer. 2001 Feb 15;91(4):854-62 [11241255.001]

[Cites] Scand J Gastroenterol. 2001 Jun;36(6):641-6 [11424324.001]

[Cites] Eur J Gastroenterol Hepatol. 2002 Jul;14(7):805-10 [12169995.001]

[Cites] Am J Gastroenterol. 2003 Aug;98(8):1682-7 [12907319.001]

[Cites] JAMA. 2003 Dec 24;290(24):3199-206 [14693872.001]

[Cites] Aliment Pharmacol Ther. 2004 Feb 1;19(3):287-93 [14984375.001]

[Cites] Inflamm Bowel Dis. 2004 Jan;10(1):32-5 [15058524.001]

[Cites] Dis Colon Rectum. 2004 May;47(5):778-81 [15037927.001]

[Cites] Eur J Gastroenterol Hepatol. 2004 Aug;16(8):767-73 [15256978.001]

[Cites] Am J Surg. 1980 Sep;140(3):396-9 [7425215.001]

[Cites] Am J Gastroenterol. 1983 Jan;78(1):44-6 [6849315.001]

[Cites] Cancer. 1983 Mar 1;51(5):878-81 [6821853.001]

[Cites] Dig Dis Sci. 1992 Aug;37(8):1179-84 [1499440.001]

[Cites] Gastroenterology. 1993 Dec;105(6):1716-23 [8253348.001]

[Cites] Gastroenterology. 1994 Dec;107(6):1675-9 [7958678.001]

[Cites] Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1179-83 [8980937.001]

[Cites] Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x [10372277.001]

[Cites] Int J Cancer. 1999 Jul 19;82(2):171-4 [10389747.001]

[Cites] Am J Gastroenterol. 1999 Jul;94(7):1746-50 [10406230.001]

[Cites] Am J Surg Pathol. 1999 Aug;23(8):963-9 [10435567.001]

[Cites] Surgery. 1956 Feb;39(2):347-51 [13298987.001]

[Cites] World J Gastroenterol. 2006 Feb 28;12(8):1317-20 [16534894.001]

[Cites] Aliment Pharmacol Ther. 2006 Apr 15;23(8):1097-104 [16611269.001]

[Cites] Am J Gastroenterol. 2006 Jul;101(7):1484-9 [16863550.001]

[Cites] Am J Gastroenterol. 2006 Oct;101(10):2218-22 [16848804.001]

[Cites] J Chemother. 2006 Oct;18(5):545-8 [17127233.001]

[Cites] JAMA. 2006 Dec 6;296(21):2590-600 [17148724.001]

[Cites] Dis Colon Rectum. 2007 Jun;50(6):839-55 [17308939.001]

[Cites] J Nucl Med. 2007 Jul;48(7):1053-9 [17574978.001]

[Cites] World J Gastroenterol. 2007 Jun 28;13(24):3279-87 [17659666.001]

[Cites] World J Gastroenterol. 2007 Dec 14;13(46):6140-9 [18069752.001]

[Cites] Am Surg. 2007 Nov;73(11):1181-7 [18092659.001]

[Cites] World J Gastroenterol. 2008 Jan 21;14(3):378-89 [18200660.001]

[Cites] Am J Gastroenterol. 2008 Jul;103(7):1730-6 [18564124.001]

[Cites] Gastroenterology. 2001 Mar;120(4):820-6 [11231935.001]

(PMID = 19360924.001).

[ISSN] 2219-2840

[Journal-full-title] World journal of gastroenterology

[ISO-abbreviation] World J. Gastroenterol.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] China

[Other-IDs] NLM/ PMC2668786

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Lack of efficacy of blueberry in nutritional prevention of azoxymethane-initiated cancers of rat small intestine and colon.

METHODS: We examined efficacy of BB in inhibition of azoxymethane (AOM)-induced colon ACF and intestine tumors in male and female Sprague-Dawley rats (outbred strain).

There was a tendency (0.1 > P > 0.05) for fewer adenocarcinomas (relative to total of adenomatous polyps plus adenocarcinomas) in colons of female than male tumor-bearing rats; in small intestine, this gender difference was significant (P < 0.05).

BB favored (P < 0.05) fewer adenocarcinomas and more adenomatous polyps (as a proportion of total tumor number) in female rat small intestine.

Data indicate the potential for slowing tumor progression (adenomatous polyp to adenocarcinoma) by BB.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] World J Gastroenterol. 2002 Oct;8(5):847-52 [12378628.001]

[Cites] Carcinogenesis. 2001 Nov;22(11):1831-5 [11698346.001]

[Cites] Cancer Lett. 2003 May 8;194(1):13-9 [12706854.001]

[Cites] Am J Clin Nutr. 2004 Feb;79(2):274-81 [14749234.001]

[Cites] Cancer Causes Control. 2003 Dec;14(10):959-70 [14750535.001]

[Cites] Nutr Cancer. 2004;49(2):131-8 [15489205.001]

[Cites] Digestion. 1976;14(4):311-8 [964470.001]

[Cites] Cancer. 1977 Nov;40(5 Suppl):2436-45 [200341.001]

[Cites] J Agric Food Chem. 2006 Dec 13;54(25):9322-8 [17147414.001]

[Cites] J Agric Food Chem. 2006 Dec 13;54(25):9329-39 [17147415.001]

[Cites] Clin Cancer Res. 2007 Jan 1;13(1):350-5 [17200374.001]

[Cites] Food Chem Toxicol. 2007 May;45(5):725-32 [17321025.001]

[Cites] Comp Med. 2002 Feb;52(1):50-7 [11900413.001]

[Cites] Nutr Cancer. 2001;40(2):125-33 [11962247.001]

[Cites] Nutr Cancer. 2001;41(1-2):145-9 [12094617.001]

[Cites] Carcinogenesis. 1996 Jan;17(1):95-8 [8565143.001]

[Cites] Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):1013-5 [8959325.001]

[Cites] Cancer Lett. 1998 Aug 14;130(1-2):29-34 [9751253.001]

[Cites] Br J Cancer. 1999 Mar;79(7-8):1283-7 [10098773.001]

[Cites] Int J Cancer. 1999 Jul 19;82(2):171-4 [10389747.001]

[Cites] Bull World Health Organ. 2005 Feb;83(2):100-8 [15744402.001]

[Cites] Cancer Causes Control. 2005 Apr;16(3):225-33 [15947874.001]

[Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1619-25 [16030092.001]

[Cites] J Agric Food Chem. 2005 Sep 7;53(18):7320-9 [16131149.001]

[Cites] Cancer Res. 2006 Apr 1;66(7):3942-53 [16585224.001]

[Cites] Mol Nutr Food Res. 2006 Apr;50(4-5):418-23 [16548015.001]

[Cites] J Nutr Biochem. 2006 Sep;17(9):626-34 [16504496.001]

[Cites] Int J Cancer. 2006 Nov 1;119(9):2213-20 [16823841.001]

[Cites] Free Radic Res. 2006 Oct;40(10):1014-28 [17015246.001]

[Cites] J Agric Food Chem. 2007 Apr 18;55(8):3180-5 [17381106.001]

[Cites] J Am Coll Nutr. 2007 Apr;26(2):170-81 [17536129.001]

[Cites] Clin Gastroenterol Hepatol. 2007 Jun;5(6):736-42 [17544999.001]

[Cites] Am J Epidemiol. 2007 Jul 15;166(2):170-80 [17485731.001]

[Cites] Semin Cancer Biol. 2007 Oct;17(5):403-10 [17574861.001]

[Cites] J Agric Food Chem. 2007 Sep 19;55(19):7777-85 [17696482.001]

[Cites] J Nutr. 2007 Oct;137(10):2285-90 [17885012.001]

[Cites] J Natl Cancer Inst. 2007 Oct 3;99(19):1471-83 [17895473.001]

[Cites] J Endocrinol. 2007 Oct;195(1):79-87 [17911399.001]

[Cites] Am J Clin Nutr. 2007 Dec;86(6):1754-64 [18065596.001]

[Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]

[Cites] Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G868-76 [18239060.001]

[Cites] Arch Physiol Biochem. 2008 Feb;114(1):63-70 [18465360.001]

[Cites] Am J Clin Nutr. 2008 Sep;88(3):730-7 [18779290.001]

[Cites] Am J Epidemiol. 2000 Dec 1;152(11):1081-92 [11117618.001]

[Cites] J Natl Cancer Inst. 2001 Apr 4;93(7):525-33 [11287446.001]

[Cites] Nutr Cancer. 2002;43(1):1-21 [12467130.001]

(PMID = 19758446.001).

[ISSN] 1471-230X

[Journal-full-title] BMC gastroenterology

[ISO-abbreviation] BMC Gastroenterol

[Language] ENG

[Grant] United States / NCI NIH HHS / CB / N02-CB-07008

[Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

[Publication-country] England

[Chemical-registry-number] 0 / C-Peptide; MO0N1J0SEN / Azoxymethane

[Other-IDs] NLM/ PMC2752457

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases.

Small intestinal adenocarcinoma is a rare malignant neoplasm, and its clinicopathologic characteristics have not been well elucidated.

A total of 197 small intestinal adenocarcinoma cases were collected from 22 institutions in South Korea and were evaluated for clinicopathologic factors that affect the prognosis of small intestinal adenocarcinoma patients using univariate and multivariate analyses.

The median survival time for all small intestinal adenocarcinoma patients was 39.7 months.

Compared with small intestinal adenocarcinomas without accompanying sporadic adenomas, small intestinal adenocarcinomas with accompanying adenomas were more well differentiated (P < .0001), with a more polypoid growth pattern (P < .0001), a lower pT classification (P < .0001), less perineural invasion (P = .01), and less lymphatic invasion (P = .03).

Small intestinal adenocarcinoma patients with associated sporadic adenomas (77%) had a significantly better 5-year survival rate than those without sporadic adenomas (38%, P = .02).

By univariate analysis, small intestinal adenocarcinoma patients had significantly different survival based on pT classification (P = .003), lymph node metastasis (P < .0001), distal location (jejunal and ileal carcinomas) (P = .003), retroperitoneal tumor seeding (P < .0001), vascular invasion (P = .007), lymphatic invasion (P = .001), peritumoral dysplasia (P = .004), and radiation therapy (P = .006).

In conclusion, (1) small intestinal adenocarcinomas are diagnosed at an advanced disease stage; therefore, the development of strategies for detection at an earlier stage is needed. (2) Small intestinal adenocarcinoma patients with an adenomatous component had a better survival than those without an adenomatous component. (3) Lymph node metastasis and distal location (jejunum and ileum) of tumor are the most important independent prognostic factors.

[MeSH-major] Adenocarcinoma / pathology. Duodenal Neoplasms / pathology. Ileal Neoplasms / pathology. Jejunal Neoplasms / pathology

[MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Intestine, Small / pathology. Kaplan-Meier Estimate. Lymphatic Metastasis / pathology. Male. Middle Aged. Prognosis

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] 2010 Elsevier Inc. All rights reserved.

(PMID = 20334897.001).

[ISSN] 1532-8392

[Journal-full-title] Human pathology

[ISO-abbreviation] Hum. Pathol.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Amyloidosis of the small intestine following whipple operation is a rare cause of chronic ileus and has to be considered as differential diagnosis].

[Transliterated title] Die Amyloidose des Dünndarms als seltene Differenzialdiagnose eines chronischen Ileus nach Whipple-Operation.

In this paper we report that secondary amyloidosis of the small intestine can produce similar symptoms and has to be evaluated as a rare differential diagnosis in chronic ileus.

Instead severe adhesions of the small intestine were detected.

The entire small intestine was covered with a substance that had a similar aspect to sugar icing.

Thereby the motility of the small intestine was constricted.

An extensive adhaesiolysis and a decompression of the bowel was carried out.

Diffuse amyloid deposits were found on the small intestine.

One man died four months later, after transfer to a geriatric hospital, because of intestinal atony and a serious senile depression.

Surgeons have to keep in mind that amyloidosis is a possible differential diagnosis in addition to relapse of tumour growth and peritoneal carcinomatosis in these patients.

[MeSH-major] Adenocarcinoma, Papillary / surgery. Amyloidosis / diagnosis. Cystadenoma, Mucinous / surgery. Ileus / diagnosis. Intestinal Diseases / diagnosis. Intestine, Small. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy. Postoperative Complications / diagnosis

[MeSH-minor] Aged. Aged, 80 and over. Chronic Disease. Diagnosis, Differential. Fatal Outcome. Female. Humans. Male. Tissue Adhesions / diagnosis. Tissue Adhesions / pathology. Tissue Adhesions / surgery

Genetic Alliance. consumer health - Amyloidosis.

MedlinePlus Health Information. consumer health - After Surgery.

MedlinePlus Health Information. consumer health - Amyloidosis.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Georg Thieme Verlag Stuttgart ˙ New York.

(PMID = 20464655.001).

[ISSN] 1438-9592

[Journal-full-title] Zentralblatt für Chirurgie

[ISO-abbreviation] Zentralbl Chir

[Language] ger

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Germany

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Solitary bone metastasis as the first clinical manifestation in a patient with small bowel adenocarcinoma.

[MeSH-major] Acetabulum. Adenocarcinoma / secondary. Bone Neoplasms / secondary. Jejunal Neoplasms / pathology

[MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Fatal Outcome. Humans. Male. Tomography, Emission-Computed, Single-Photon. Tomography, X-Ray Computed

MedlinePlus Health Information. consumer health - Bone Cancer.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18040646.001).

[ISSN] 0949-2658

[Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

[ISO-abbreviation] J Orthop Sci

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Japan

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] A patient with adenocarcinoma of the jejunum successfully diagnosed by preoperative endoscopy for the small intestine.

In this study, the authors report the case of a 35-year-old man diagnosed preoperatively as having adenocarcinoma of the jejunum using a conventional endoscopy, usually used for the examination of the large intestine.

[MeSH-major] Adenocarcinoma / pathology. Endoscopy. Jejunal Neoplasms / pathology

[MeSH-minor] Adult. Humans. Ileus / diagnosis. Ileus / etiology. Ileus / surgery. Intestine, Small. Male

MedlinePlus Health Information. consumer health - Endoscopy.

MedlinePlus Health Information. consumer health - Intestinal Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18795691.001).

[ISSN] 0172-6390

[Journal-full-title] Hepato-gastroenterology

[ISO-abbreviation] Hepatogastroenterology

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Greece

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

BACKGROUND: Barrett's oesophagus is an important clinical problem that can lead to oesophageal adenocarcinoma.

To determine the feasibility of using EDTA to strip intestinal type mucosa, segments of the small intestine were exposed in vitro to EDTA at various concentrations with or without agitation.

The conditions required for EDTA to strip mucosa from a vascularized loop of small bowel were then optimized in vivo.

Cannulated small bowel loops were irrigated with different concentrations of EDTA with or without pulsation of the irrigation solution.

Mucosal healing after EDTA stripping was studied in an isolated small bowel loop survival model.

RESULTS: Ethylenediaminetetraacetic acid with agitation or pulsation resulted in stripping of the intestinal columnar mucosa in vitro and in vivo.

In the survival model the small bowel mucosa regenerated without stricture formation.

CONCLUSION: Small bowel columnar mucosa can be removed by EDTA in vivo without stricture formation.

[MeSH-major] Chelating Agents / pharmacology. Edetic Acid / pharmacology. Esophagus / drug effects. Intestinal Mucosa / drug effects. Jejunum / drug effects

COS Scholar Universe. author profiles.

Hazardous Substances Data Bank. Disodium EDTA .

Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .

Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16768702.001).

[ISSN] 1445-1433

[Journal-full-title] ANZ journal of surgery

[ISO-abbreviation] ANZ J Surg

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] Australia

[Chemical-registry-number] 0 / Chelating Agents; 9G34HU7RV0 / Edetic Acid

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

These tumours originate in Cajal interstitial cells and the majority are located in the stomach and small intestine.

Imaging difficulties impede an early diagnosis; sometimes these tumours represent an unexpected intraoperative finding or an emergency abdominal picture.

One patient, with two synchronous gastric neoplasms (GIST + adenocarcinoma) died after 16 months, while the other 5 patients with gastric GIST are still alive; two patients with ileal GIST, treated with chemotherapy, died after 15 and 18 months, respectively.

MedlinePlus Health Information. consumer health - Stomach Cancer.

Hazardous Substances Data Bank. IMATINIB MESYLATE .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19536989.001).

[ISSN] 0009-4773

[Journal-full-title] Chirurgia italiana

[ISO-abbreviation] Chir Ital

[Language] ita

[Publication-type] English Abstract; Journal Article

[Publication-country] Italy

[Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Colonic cancer in a patient with intestinal malrotation: a case report.

We present a case of a 76-year-old patient with intestinal malrotation, with incomplete rotation of the small intestine and abnormal positioning of the duodenum and superior mesenteric vessels over the transverse colon.

[MeSH-major] Adenocarcinoma / complications. Colonic Neoplasms / complications. Digestive System Abnormalities / complications. Intestinal Diseases / congenital. Intestines / abnormalities

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] World J Gastroenterol. 2006 Sep 7;12(33):5399-400 [16981277.001]

[Cites] J Am Coll Surg. 2004 Oct;199(4):628-35 [15454150.001]

[Cites] Radiographics. 2002 Nov-Dec;22(6):1439-56 [12432114.001]

[Cites] J Anat. 1976 Nov;122(Pt 2):377-88 [1002609.001]

[Cites] Abdom Imaging. 1999 Nov-Dec;24(6):550-5 [10525804.001]

(PMID = 20683743.001).

[ISSN] 1128-045X

[Journal-full-title] Techniques in coloproctology

[ISO-abbreviation] Tech Coloproctol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Italy

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Patients with long-standing ulcerative colitis and Crohn's disease have an increased risk of developing colorectal cancer and patients with small intestinal Crohn's disease are at increased risk of small bowel adenocarcinoma.

Colorectal cancer appearing on the ground of inflammatory bowel disease is the result of a process which is believed to begin from no dysplasia progressing to indefinite dysplasia, low-grade dysplasia, high-grade dysplasia and finally to invasive adenocarcinoma, although colorectal cancer can arise without proceeding through each of these steps.

[MeSH-major] Cell Transformation, Neoplastic. Colorectal Neoplasms / epidemiology. Inflammatory Bowel Diseases / epidemiology

Genetic Alliance. consumer health - Colorectal Cancer.

MedlinePlus Health Information. consumer health - Colorectal Cancer.

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19596953.001).

[ISSN] 1791-7530

[Journal-full-title] Anticancer research

[ISO-abbreviation] Anticancer Res.

[Language] eng

[Publication-type] Journal Article; Review

[Publication-country] Greece

[Number-of-references] 94

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.

CDX2 and liver-intestine (LI)-cadherin are intestine-specific markers and both are physiologically expressed in the small intestine and colon.

Overexpression of CDX2 was significantly associated with CDH17 in gastric adenocarcinoma.

Furthermore, the expression of CDX2 and LI-cadherin proteins was strongly coupled in intestinal metaplasia.

[MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Cadherins / metabolism. Homeodomain Proteins / metabolism. Stomach Neoplasms / metabolism

MedlinePlus Health Information. consumer health - Stomach Cancer.

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15732140.001).

[ISSN] 0022-3417

[Journal-full-title] The Journal of pathology

[ISO-abbreviation] J. Pathol.

[Language] eng

[Publication-type] Journal Article

[Publication-country] England

[Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDH17 protein, human; 0 / CDX2 protein, human; 0 / Cadherins; 0 / Homeodomain Proteins; 0 / Neoplasm Proteins; 0 / RNA, Messenger

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database.

BACKGROUND: The presence of distant metastases and the completeness of resection are important prognostic factors in patients with small bowel adenocarcinoma (SBA); however, the influence of lymph node metastasis on patient outcome has not been well characterized.

[MeSH-major] Adenocarcinoma / pathology. Intestinal Neoplasms / pathology. Intestine, Small. Lymph Nodes / pathology

COS Scholar Universe. author profiles.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright © 2010 American Cancer Society.

(PMID = 20715162.001).

[ISSN] 0008-543X

[Journal-full-title] Cancer

[ISO-abbreviation] Cancer

[Language] eng

[Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Helicobacter pylori is a Gram-negative spiral bacterium that causes gastritis and peptic ulcer and has been implicated in the pathogenesis of gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma.

We demonstrate here that Peyer's patches (PPs) in the small intestine play critical roles in H. pylori-induced gastritis; no gastritis is induced in H. pylori-infected mice lacking PPs.

We propose that H. pylori converts to the coccoid form in the anaerobic small intestine and stimulates the host immune system through PPs.

MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] J Exp Med. 2000 Mar 6;191(5):771-80 [10704459.001]

[Cites] Microbes Infect. 2006 Feb;8(2):442-9 [16243563.001]

[Cites] Mol Microbiol. 2000 Sep;37(6):1389-404 [10998171.001]

[Cites] Annu Rev Microbiol. 2000;54:615-40 [11018139.001]

[Cites] Blood. 2001 Feb 1;97(3):812-4 [11157503.001]

[Cites] N Engl J Med. 2001 Sep 13;345(11):784-9 [11556297.001]

[Cites] Trends Immunol. 2001 Oct;22(10):556-60 [11574279.001]

[Cites] Nat Immunol. 2001 Dec;2(12):1138-43 [11702064.001]

[Cites] J Immunol. 2002 Jan 1;168(1):57-64 [11751946.001]

[Cites] Infect Immun. 2002 Jun;70(6):3295-9 [12011029.001]

[Cites] Infect Immun. 2003 Feb;71(2):794-800 [12540559.001]

[Cites] J Immunol. 2003 Jun 1;170(11):5475-82 [12759424.001]

[Cites] J Immunol. 2004 Feb 1;172(3):1333-9 [14734707.001]

[Cites] Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6110-5 [15071180.001]

[Cites] J Immunol. 2004 Jul 15;173(2):1249-57 [15240717.001]

[Cites] J Exp Med. 2004 Oct 18;200(8):979-90 [15492123.001]

[Cites] Infect Immun. 2004 Nov;72(11):6738-42 [15501814.001]

[Cites] Am J Dermatopathol. 1979 Spring;1(1):39-42 [549479.001]

[Cites] Epidemiol Infect. 1993 Dec;111(3):483-90 [8270008.001]

[Cites] Microbiology. 1994 Oct;140 ( Pt 10):2649-56 [8000535.001]

[Cites] Immunity. 1995 Mar;2(3):223-38 [7697543.001]

[Cites] Gastroenterology. 1996 Jun;110(6):1969-74 [8964425.001]

[Cites] J Exp Med. 1997 Feb 3;185(3):499-505 [9053450.001]

[Cites] Clin Diagn Lab Immunol. 1997 May;4(3):285-90 [9144365.001]

[Cites] Scand J Rheumatol. 1998;27(3):215-8 [9645417.001]

[Cites] Immunity. 1998 Nov;9(5):669-76 [9846488.001]

[Cites] Infect Immun. 1999 Jan;67(1):337-41 [9864234.001]

[Cites] Int Immunol. 1999 May;11(5):643-55 [10330270.001]

[Cites] Science. 1999 May 21;284(5418):1328-33 [10334982.001]

[Cites] FEMS Microbiol Lett. 1999 Jun 1;175(1):107-11 [10361715.001]

[Cites] FEMS Immunol Med Microbiol. 1999 Jun;24(2):221-5 [10378424.001]

[Cites] Infect Immun. 1999 Sep;67(9):4594-602 [10456905.001]

[Cites] Trends Immunol. 2005 Apr;26(4):199-207 [15797510.001]

[Cites] Nat Rev Microbiol. 2005 Apr;3(4):320-32 [15759043.001]

[Cites] Gastroenterology. 2005 Jul;129(1):142-55 [16012944.001]

[Cites] Infect Immun. 2005 Sep;73(9):5612-9 [16113278.001]

[CommentIn] Gastroenterology. 2007 Sep;133(3):1044-5 [17854610.001]

(PMID = 17502608.001).

[ISSN] 0027-8424

[Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America

[ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Antigens, Bacterial; 0 / DNA-Binding Proteins; 0 / Rag2 protein, mouse

[Other-IDs] NLM/ PMC1885612